Enable Injections, Inc.
Enable's body-worn enFuse® drug delivery technology delivers large volumes (5 - 25mL) via subcutaneous administration.
Cincinnati, United States
189 employees
Series C
Total: $347.00M
Health Care, Life Sciences +2
General Information
Get notified when Enable Injections, Inc. moves
Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.
Track Enable Injections, Inc.
Get real-time alerts for funding, hiring, news, and 40+ signal types.
See how it worksDiscover More
United States Market
Health Care
About Enable Injections, Inc.
Taxonomy: drug delivery technology, subcutaneous administration, biologic delivery, wearable technology, biopharmaceuticals, startup company, venture capital, biomedical engineering, connected health, patient-centric technology, wearable injector, smartphone integration, biologic drug delivery
Funding Rounds & Investors (8)
View All| Funding Stage | Amount | Investors | Lead Investors | Date |
|---|---|---|---|---|
| Series C | •••••• | 8 |
|
27 Jan 2022 |
| Debt Financing | •••••• | 1 | •••• •••• | 08 Sep 2020 |
| Debt Financing | •••••• | - | 01 Jan 2020 | |
| Series B | •••••• | 7 |
|
25 Oct 2018 |
| Series A | •••••• | 6 |
|
05 Oct 2016 |
Enable Injections, Inc. Alternatives & Competitors
From Hospital to Home Care: Drug Delivery Solutions Across the Continuum of Care
Delivering Innovative Injection Solutions.
We CARE. We CREATE. We DELIVER.
FAQ About Enable Injections, Inc.
Don't just browse. Track.
Signal Tracker monitors Enable Injections, Inc. and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.
